Novo Nordisk A/S
NYSE:NVO
Novo Nordisk A/S
NYSE:NVO
Price:
44.06
USD
-6.63%
Market Cap:
$196.2B
Relative Value
The Relative Value of one
NVO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 44.06 USD,
Novo Nordisk A/S
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NVO Relative Value
HIDDEN
Multiples Across Competitors
NVO Competitors Multiples
Novo Nordisk A/S Competitors
Novo Nordisk A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
NYSE:NVO
|
1.3T USD | 4 | 12.3 | 8.6 | 10 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.2B USD | 16.4 | 52.8 | 35.5 | 38 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571.3B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.8B USD | 4.7 | 16.7 | 10.4 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.6B CHF | 5.2 | 20.3 | 12.8 | 16.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.9B GBP | 5.2 | 32 | 15.3 | 22.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD | 2.5 | 19.7 | 7 | 9.1 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
